The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor γ ligands
- 24 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 332 (1) , 188-193
- https://doi.org/10.1016/j.bbrc.2005.04.110
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Genomic Organization and Evolution of the CX3CR1/CCR8 Chemokine Receptor LocusJournal of Biological Chemistry, 2003
- Cloning and functional characterization of the human fractalkine receptor promoter regionsBiochemical Journal, 2002
- Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator–activated receptor γJournal of Clinical Investigation, 2000
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient miceJournal of Clinical Investigation, 2000
- Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle CellsCirculation, 2000
- Cloning and Functional Characterization of the 5′-Flanking Region of the Human Monocyte Chemoattractant Protein-1 Receptor (CCR2) GenePublished by Elsevier ,1999
- Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by CytokinesPublished by Elsevier ,1997
- Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.Proceedings of the National Academy of Sciences, 1994